SEC EDGAR Filing Information

Form SC 13G -- Statement of acquisition of beneficial ownership by individuals

Filing Date Changed: 2007-01-12
Documents: 1

SEC Accession No.
0000950162-07-000038
Filing date: 2007-01-12
Accepted: 2007-01-12 16:04:51

Table of submitted documents:

Seq	Type	Document	Size	Description
1	SC 13G	sigmataupharm13g_010307.htm	334477	DOR BIOPHARMA/SIGMA-TAU PHARMACEUTICALS, INC. SCHEDULE 13G - 01/03/07

		0000950162-07-000038.txt	336627	Complete submission text file

Filer Information:

DOR BIOPHARMA INC (Subject) (0000812796)
IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-39976 | Film No.: 07528861
SIC: 2834 Pharmaceutical Preparations

Assistant Director 1

Business Address
1101 BRICKELL AVENUE
SUITE 701 S
MIAMI FL 33131
305-534-3383

Mailing Address
1101 BRICKELL AVENUE
SUITE 701 S
MIAMI FL 33131

Sigma-Tau Pharmaceuticals, Inc. (Filed by) (0001385625)
IRS No.: 953566292 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SC 13G | Act: | Film No.:

Business Address
800 SOUTH FREDERICK AVENUE
SUITE 300
GAITHERSBURG MD 20877
1-800-447-0169

Mailing Address
800 SOUTH FREDERICK AVENUE
SUITE 300
GAITHERSBURG MD 20877